Devonian Health Group, Inc. (TSE:GSD) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Devonian Health Group Inc. has announced the appointment of its founder, Dr. André P. Boulet, as the new Chairman of the Board and Chief Operating Officer while retaining his role as Chief Scientific Officer. With a strong background in drug development and a wealth of industry experience, Dr. Boulet’s leadership is aimed to streamline the company’s research and scale-up initiatives. The outgoing Chairman, Mr. David Baker, will continue his involvement as a board member.
For further insights into TSE:GSD stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue